VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ASRT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ASRTAssertio Holdings, Inc.
$23.50$152M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksASRTBalance Sheet

Assertio Holdings, Inc. (ASRT) Balance Sheet

30Y historyFree accessUpdated daily

Financial stability is increasingly fragile, as evidenced by the expansion of the retained earnings deficit to $722.4 million and a significant reduction in goodwill to $43.1 million.

ASRT Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets166.85M216.65M202.55M171.06M132.26M103.5M94.25M103.95M215.92M231.72M307.66M316.65M622.05M314.59M108.34M109.49M79.6M78.43M93.99M62.77M47.88M63M18.55M45.23M21.05M6.39M7.12M21.65M7.2M4.4M200K
Cash & Short-Term Investments71.57M63.41M100.05M73.44M64.94M36.81M20.79M42.11M110.95M128.09M177.42M209.77M566.4M276.02M77.89M86.15M70.35M69.74M82.06M53.47M31.56M59.07M18.1M44.26M20.22M5.15M6.5M4.47M4.1M4.1M0
Cash Only33.71M10.23M50.59M73.44M64.94M36.81M20.79M42.11M110.95M128.09M177.42M209.77M566.4M276.02M77.89M24.04M22.53M26.82M22.13M14.37M14.57M7.57M953.29K20.04M11.53M5.15M3.88M934.32K4.1M4.1M0
Short-Term Investments37.86M53.18M49.47M00000000000062.11M47.83M42.92M59.93M39.09M16.98M51.51M17.15M24.21M8.68M02.62M3.53M000
Accounts Receivable61.53M120.11M54.12M47.66M45.36M43.75M44.35M42.74M37.21M72.48M102.59M78.05M28.08M22.27M13.69M12.55M6.35M4.93M3.67M3.62M9.08M1.96M0278.45K301.87K1.04M454.09K17.02M300K100K100K
Days Sales Outstanding354.83369.3158.08114.4105.96143.85149.7867.9743.5669.4982.1383.1126.2560.5855.0334.4628.6831.1938.520.16347.07162.1-103.566.33103.3593.3153.85K136.8860.83121.67
Inventory23.01M24.12M38.31M37.69M13.7M7.49M11.71M3.41M3.4M13.04M13.03M10.49M8.46M10.14M9.59M5.39M1.57M2.56M2.85M3.26M4.48M864.79K000000000
Days Inventory Outstanding168.07134.64356.45509.08266.64172.66271.04131.0267.0965.5754.4256.41203.78522.2579.44355.1970.82178.09180.16458.61.02K347.43---------
Other Current Assets336K9.01M10.07M299K0608K00000013.63M26.86M0001.08M0038736.56K0000168.67K169.38K2.8M200K100K
Total Non-Current Assets44.44M50.32M82.18M115.36M281.65M223.05M209.02M423.22M716.95M806.9M917.67M1.05B89.02M194.06M33.31M54.88M7.43M13.15M1.1M17.88M4.74M3.38M4.32M2.47M2.13M2.36M1.61M784.1K3.1M200K100K
Property, Plant & Equipment1.34M444K1.71M2.04M881K2.26M4.39M3.5M13.06M13.02M15.53M14.79M7.05M8.34M8.24M1.07M698K942K900K1.62M2.54M3.15M3.94M2.14M1.83M2.07M1.32M779.63K1M200K200K
Fixed Asset Turnover106.77x267.37x73.03x74.58x177.34x49.08x24.61x65.64x23.86x29.23x29.36x23.17x55.33x16.09x11.03x124.27x115.71x61.28x38.71x40.46x3.76x1.40x0.05x0.46x0.91x1.78x1.35x0.15x0.80x3.00x1.50x
Goodwill0000000000000000000000000000000
Intangible Assets43.1M48.91M80.47M111.33M198M216.05M200.08M400.54M692.1M793.87M902.15M1.01B72.36M82.52M25.08M0000000000000000
Long-Term Investments0000268K1.58M1.58M13.06M11.78M00-7.68M6.96M4.08M11.08M53.64M6.54M12.02M0000000000000
Other Non-Current Assets0972K1K1.99M2.3M3.15M2.97M6.12M7.81M007.68M-6.96M-4.08M1.99M169K197K197K197K16.25M2.2M228.93K380.27K326.14K291.88K294.03K293.76K4.47K2.1M0-100K
Total Assets211.3M266.97M284.73M286.42M413.91M326.55M303.27M527.17M932.87M1.04B1.23B1.36B711.07M508.65M141.65M164.37M87.03M91.58M95.08M80.64M52.62M66.38M22.87M47.69M23.18M8.75M8.73M22.43M10.3M4.6M300K
Asset Turnover0.38x0.44x0.44x0.53x0.38x0.34x0.36x0.44x0.33x0.37x0.37x0.25x0.55x0.26x0.64x0.81x0.93x0.63x0.37x0.81x0.18x0.07x0.01x0.02x0.07x0.42x0.20x0.01x0.08x0.13x1.00x
Asset Growth %-18.63%-6.24%-0.59%-30.8%26.75%7.67%-42.47%-43.49%-10.18%-15.24%-10.13%91.75%39.79%259.08%-13.82%88.87%-4.97%-3.68%17.9%53.27%-20.73%190.26%-52.05%105.76%165%0.16%-61.08%117.81%123.91%1433.33%-
Total Current Liabilities91.57M127.51M114.69M93.44M95.32M135.02M132.69M184.55M124.9M224.4M221.77M196.79M52.69M119.23M51.37M39.84M32.98M32.2M22.38M14.33M22.34M8.07M3.47M3.62M8.57M4.66M2.38M12.81M600K400K700K
Accounts Payable5.91M9.01M14.74M13.44M5.99M6.68M14.81M16.19M6.14M14.73M14.86M12.8M1.28M2.23M2.36M2.42M1.66M709K559K1.13M4.89M1.59M1.73M2.02M4.8M2.33M797.79K219.68K200K300K100K
Days Payables Outstanding64.8850.32137.12181.54116.64154.12342.69621.82121.2674.0762.0368.8430.8114.89142.64159.1374.649.2335.35159.381.11K638.38-----518.36-124.6-146-547.5-
Short-Term Debt220K000470K12.17M11.94M80M120M82.5M466.05M563.47M00002.17M3.75M3.36M000105.42K315.94K435.72K556.24K178.62K164.17K200K0300K
Deferred Revenue (Current)000000086.27M-2.37M135.83M131.54M121.06M015.52M18.79M12.99M11.71M12.82M4.36M1.45M4.6M3.57M75K03.03M790.18K00000
Other Current Liabilities84.05M118.5M96.36M6.09M30.36M47.65M20.02M-82.5M2.71M13.29M-460.52M-559.31M2.13M132.2M26.03M21.2M635K414K110K6.54M4.88M138.56K93.07K0305.17K983.56K1.4M12.42M200K100K300K
Current Ratio1.82x1.70x1.77x1.83x1.39x0.77x0.71x0.56x1.73x1.03x1.39x1.61x11.81x2.64x2.11x2.75x2.41x2.44x4.20x4.38x2.14x7.81x5.34x12.50x2.46x1.37x3.00x1.69x12.00x11.00x0.29x
Quick Ratio1.57x1.51x1.43x1.43x1.24x0.71x0.62x0.54x1.70x0.97x1.33x1.56x11.65x2.55x1.92x2.61x2.37x2.36x4.07x4.15x1.94x7.70x5.34x12.50x2.46x1.37x3.00x1.69x12.00x11.00x0.29x
Cash Conversion Cycle458.02453.62377.41441.94255.97162.3978.13-422.83-10.6160.9974.5370.69199.23467.89491.83230.5224.9160.05183.31319.39255.21-128.86---------
Total Non-Current Liabilities44.09M45.51M48.96M54.97M92.87M89.11M115.07M284.66M587.63M644.71M752.78M851.58M293.93M252.01M6.35M18.61M30.94M43.65M39.55M20.79M57.57M51.55M10.99M9.5M21.02M5.57M1.77M410.6K500K100K0
Long-Term Debt39.25M39.12M38.81M38.21M66.4M61.32M72.16M271.26M446.11M544.23M718.78M800.33M229.89M00002.17M5.78M00010.28M9.49M385.22K5.56M1.77M410.6K500K00
Capital Lease Obligations1.84M01.12M1.47M0397K2.81M4.82M00000000000000012.81K04.22K00000
Deferred Tax Liabilities2.43M004.55M4.27M000000032.59M000000000000000000
Other Non-Current Liabilities4M6.38M9.03M10.74M22.2M27.4M40.1M8.58M20.39M14.3M28.53M22.24M26.64M201.91M5.52M682K15K177K33.78M20.79M57.57M124.1K710.92K020.63M0000100K0
Total Liabilities135.67M173.02M163.65M148.42M188.19M224.13M247.76M469.21M712.53M869.11M974.55M1.05B346.62M371.24M57.72M58.45M63.92M75.86M61.93M35.13M79.91M59.62M14.47M13.12M29.59M10.22M4.15M13.22M1.1M500K700K
Total Debt40.31M39.12M40.27M39.68M66.87M75.87M89.6M358.17M566.11M626.73M718.78M806.51M229.89M0002.17M5.92M9.13M00010.39M9.81M820.94K6.12M1.95M574.77K700K0300K
Net Debt6.6M28.89M-10.32M-33.77M1.93M39.06M68.81M316.06M455.16M498.64M541.36M596.74M-336.51M-276.02M-77.89M-24.04M-20.36M-20.9M-13M-14.37M-14.57M-7.57M9.43M-10.23M-10.71M972.83K-1.93M-359.54K-3.4M-4.1M300K
Debt / Equity0.53x0.42x0.33x0.29x0.30x0.74x1.61x6.18x2.57x3.70x2.87x2.56x0.63x---0.09x0.38x0.28x---1.24x0.28x--0.42x0.06x0.08x--
Debt / EBITDA10.54x3.06x29.76x-0.92x1.97x--3.77x9.90x5.37x24.48x0.93x---0.53x--------------
Net Debt / EBITDA1.73x2.26x-7.63x-0.03x1.01x--3.03x7.87x4.04x18.11x-1.36x-19.91x--0.34x-5.01x---0.30x-----------
Interest Coverage-7.38x-5.60x-6.81x7.38x7.13x0.95x-2.68x-0.09x1.55x-0.41x0.23x-0.68x9.91x1.95x-764.95x535.75x7.80x-21.00x-26.57x---57.67x-28.35x-32.29x-38.81x-136.13x-----
Total Equity75.63M93.95M121.08M138M225.72M102.41M55.51M57.96M220.34M169.51M250.79M315.06M364.45M137.42M83.94M105.92M23.11M15.73M33.15M45.52M-27.29M6.76M8.4M34.58M-6.41M-1.48M4.59M9.22M9.2M4.1M-400K
Equity Growth %-101.06%-22.41%-12.26%-38.86%120.4%84.48%-4.22%-73.7%29.98%-32.41%-20.4%-13.55%165.21%63.72%-20.75%358.4%46.93%-52.57%-27.17%266.81%-503.62%-19.54%-75.7%639.08%-334.19%-132.21%-50.25%0.2%124.39%1125%-
Book Value per Share11.7614.6719.0629.1461.9335.5931.7749.18205.89162.20245.51314.44329.78143.2890.10113.3025.9818.3140.7858.92-39.4410.1914.5684.82-26.28-8.6737.5485.4387.3755.35-5.76
Total Shareholders' Equity75.63M93.95M121.08M138M225.72M102.41M55.51M57.96M220.34M169.51M250.79M315.06M364.45M137.42M83.94M105.92M23.11M15.73M33.15M45.52M-27.29M6.76M8.4M34.58M-6.41M-1.48M4.59M9.22M9.2M4.1M-400K
Common Stock1K1K9K9K5K4K3K8K6K313.86M291.63M264.51M239.96M221.12M211.27M000000139.64M117.07M116.54M56.68M36.11M24.6M14.8M000
Retained Earnings-722.36M-703.5M-673.12M-651.54M-319.6M-429.23M-427.94M-399.8M-182.6M-219.51M-116.74M-28.02M47.71M-84.05M-127.36M-97.58M-168.31M-172.2M150.19M-134.89M-184.11M-144.45M-119.98M-93.11M-63.1M-51.32M-32.81M-22.3M-5.1M-2.3M-1.1M
Treasury Stock0000000000000000000-134.89M00000000000
Accumulated OCI00000000-5K-5K-19K-54K-37K-7K31K-13K69K33K151K110K-12.81K-442.7K-698.02K-868.7K2.74K0-28.12K16.72M000
Minority Interest0000000000000000000000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity and solvency pressure

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Rapid Asset Base Erosion Observed

According to the company's latest balance sheet data, total assets have declined from $286.4 million in 2023Q4 to $211.3 million in 2026Q1, reflecting a consistent contraction that suggests the firm is struggling to replace the value of its aging specialty pharmaceutical portfolio through organic or inorganic means.

The steady decline in total assets, coupled with a significant reduction in goodwill, indicates that the company is effectively shrinking its footprint as legacy assets lose market relevance. Investors should monitor whether this trajectory represents a managed wind-down or an inability to execute on a growth-oriented capital allocation strategy.

Cash Runway Nearing Critical Thresholds

As reported in recent financial filings, the company's cash position plummeted to $10.2 million by 2025Q4, representing a sharp decline from the $80.7 million held in 2024Q1, which significantly limits the firm's operational flexibility and its ability to absorb further negative cash flow shocks.

While the current ratio remains above 1.0, the absolute level of cash is insufficient to support the company's high fixed-cost structure for an extended period. This liquidity profile suggests that the firm may face imminent pressure to secure additional financing or divest assets to maintain basic operations.

Accumulated Deficit Weighs on Equity

Based on the company's reported figures, the retained earnings deficit has expanded to $722.4 million as of 2026Q1, a clear indicator that historical capital allocation and operational losses have severely eroded the book value of shareholder equity over the observed ten-quarter period.

The persistent growth of the accumulated deficit highlights the structural inability of the current business model to generate positive returns on invested capital. This trend suggests that equity holders are effectively funding ongoing operational losses, which may lead to further dilution if the company attempts to recapitalize.

Goodwill Impairment Risks Remain Elevated

Data from the balance sheet shows that goodwill has been written down from $111.3 million in 2023Q4 to $43.1 million in 2026Q1, which implies that the company is aggressively adjusting the carrying value of its past acquisitions to reflect their diminished commercial potential in the current market.

The rapid pace of these write-downs suggests that the assets acquired in previous periods are failing to meet original performance expectations. Analysts should consider whether the remaining goodwill balance is still overstated, as further impairments could lead to additional volatility in the company's reported equity position.

ASRT — Frequently Asked Questions

Quick answers to the most common questions about buying ASRT stock.

What are the total assets of Assertio Holdings, Inc. (ASRT)?

As of 2025, Assertio Holdings, Inc. (ASRT) had total assets of $267.0M including $216.6M in current assets.

How much debt does Assertio Holdings, Inc. (ASRT) have?

Assertio Holdings, Inc. (ASRT) carries total debt of $39.1M, offset by $63.4M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Assertio Holdings, Inc.?

Assertio Holdings, Inc. (ASRT) has total shareholders' equity (book value) of $94.0M ($14.67 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Assertio Holdings, Inc.'s current ratio and liquidity?

Assertio Holdings, Inc. (ASRT) reported a current ratio of 1.70x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.